INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›science›Regulatory: Approvals for Eisai, Telix and more
science

Regulatory: Approvals for Eisai, Telix and more

By Info60 World Desk•Summary of reporting by Bioworld•Sep 22, 2026•0 views•
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Biogen, Eisai, GSK, H. Lundbeck, Icecure, Nicox, Nutromics, Ocumension, Takeda, Telix, Viatris.
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Deals/M&As: Adagene milestone; Elix-Axcelead research pact

Bioworld

Clinics: NSCLC data from Akeso, Leads, Taiho and more

Bioworld

A&As: Armour named Alpha Fusion CMO

Bioworld

Financings: Cambium raises $7.74M

Bioworld

“第2の月” か? アポロ13号関連部品か? 小天体「Sar2901」に注目が集まる(sorae 宇宙へのポータルサイト) - Yahoo!ニュース

Google News

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!